Confirmed group N = 212 | Clinical group N = 275 | Probable group N = 431 | All Cases N = 918 | P | |
---|---|---|---|---|---|
Gender n (%) | |||||
Male | 119 (56.1) | 194 (70.5) | 271 (62.9) | 584 (63.6) | 0.004 |
Female | 93 (43.9) | 81 (29.5) | 160 (37.1) | 334 (36.4) | |
Age n (%) | |||||
Neonates | 120 (56.6) | 136 (49.5) | 152 (35.3) | 408 (44.4) | < 0.001 |
1–2 months | 47 (22.2) | 70 (25.5) | 113 (26.2) | 230 (25.1) | |
3–12 months | 24 (11.3) | 31 (11.3) | 112 (26.0) | 167 (18.2) | |
1–14 years | 21 (9.9) | 38 (13.8) | 54 (12.5) | 113 (12.3) | |
Length of stay (day) | |||||
M (IQR) | 29 (26) | 23 (18) | 15 (8) | 20 (16) | < 0.001 |
Average cost CNY | |||||
M (IQR) | 35,824 (438,217) | 27,768 (30,446) | 16,209 (11,228) | 21,531 (24,835) | < 0.001 |
Prognosis n (%) | |||||
Cure and improved | 188 (88.7) | 264 (96.0) | 415 (96.3) | 867 (94.4) | < 0.001 |
Cure | 61 (28.8) | 95 (34.5) | 156 (36.2) | 312 (33.9) | 0.017 |
Improved | 127 (59.9) | 169 (61.5) | 259 (60.1) | 555 (60.5) | |
Not healed | 18 (8.5) | 8 (2.9) | 12 (2.8) | 38 (4.1) | |
Death | 6 (2.8) | 3 (1.1) | 4 (0.9) | 13 (1.4) |